Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 12;12:999654. doi: 10.3389/fonc.2022.999654

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Li, Liu, Chen, Zhang, Wu and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Patients with different clinicopathological features (including age, FIGO stage and Grade) had different levels of risk scores in TCGA-RNA-Seq cohort (A) and HG-U133_Plus_2 cohort (B). Stratification analysis suggested that the immune-related lncRNAs signature retained its prognostic value in multiple subgroups in TCGA-RNA-Seq cohort (C) and HG-U133_Plus_2 cohort (D). The younger and older group were divided based on 50y; FIGO I+II were identified as early stage and FIGO III+IV were identified as advanced stage; G1+G2 were identified as early grade and G3+G4 were identified as advanced grade.